Affini-T Therapeutics
PrivateLast Round
VC Round
Oct 15, 2024
Total Funding Raised
$180M
Company Overview
Affini-T Therapeutics is a biotechnology company that develops precision-engineered T-cell receptor (TCR) therapies targeting oncogenic driver mutations to treat solid tumors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Affini-T Therapeutics Comparables
Compare Affini-T Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| OncoVanta Therapeutics | 84% | |
| Hula Therapeutics | 83% | |
| T-knife Therapeutics | 81% | |
Affini-T Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 15, 2024 | ||||
| Series B Extension | Aug 1, 2024 | ||||
| Series A | Mar 22, 2022 | ||||
| Seed | Dec 24, 2020 |
Affini-T Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Agent Capital | Series A |
| Vida Ventures | Series A |
| Parker Institute for Cancer Immunotherapy | Series A |
| Catalio Capital Management | Series A |
| Humboldt Fund | Series A |
| Alexandria Venture Investments | Series A |
| Leaps by Bayer | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 9, 2025
Will present at the 43rd Annual J.P. Morgan Healthcare Conference.
- Aug 1, 2024
Raised Series B Extension round with Metagenomi participating.
Affini-T Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Affini-T Therapeutics's valuation, stock price, and market status.